Arabic Arabic English English French French German German
dark

New marker predicts benefit of radiotherapy for early-stage breast cancer

A study involving researchers at Karolinska Institutet and Gothenburg University in Sweden has found that low levels of a protein called PDGFRb are associated with particularly good results of radiotherapy in women with early-stage breast cancer. The study, which is published in the journal Clinical Cancer Research, also suggests that the efficacy of radiotherapy can be improved with drugs that block this protein. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Cumulus Neuroscience raises £6m in Dementia Discovery Fund-led financing round

Next Post

Examining the ‘service cliff’ for youth with autism and their family caregivers

Related Posts
Total
0
Share